Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
61/100
Pipeline Velocity
34/100
Trial Completion Rate
100/100
Pipeline Concentration
50/100
Pipeline Freshness
81/100
Strategic Signals
Activity
Last 14 days
Effects of Dorsolateral Prefrontal Cortex rTMS Primed Dual-Task Gait Training on Walking and Cognitive Outcomes After Stroke: A Randomized Sham-Controlled Trial
Enhancing BSN Students' Career Motivation in Supporting Underprivileged Older Adults Through a Community Practice Program: A Wait-list Randomized Controlled Study
A Feasibility Study of an mHealth-based Healthcare Professional-Lay Health Worker Partnership Program (mHLPP) Among Community-dwelling Impoverished Older Adults
Combining Machine Learning and Ecological Momentary Assessment of Depression, Cognitive Function and Daily Activity Behavior to Support Self-Management for Post-stroke Patients: A Feasibility Study
Effects of Morning Bright Light Therapy on Sleep, Alertness, Mood, and Cognition in Healthy University Students: A Randomized Crossover Trial
Circadian Match and Mismatch Effects on Temporal Cognition in Morning- and Evening-Type Adults
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)